Project description
Dr. Harikesh Dubey is a postdoctoral research associate at the Institute for Quantitative Health Science & Engineering, Michigan State University working with Dr. Rebecca Knickmeyer.
His current research focused to study the effect of gut microbiomes (collected from human infants) on brain structure and functions in various mouse models of autism spectrum disorder (ASD).
Dr. Dubey is also interested in understanding how gut microbiome contribute to co-occurring strengths and challenges in ASD. Dr. Dubey's research will help developing a novel microbiome-based intervention to treat ASD and related complications.
USA's winning projects
Fecal microbiome and association with clinical outcome and the tumor microenvironment in patients receiving pre-operative pembrolizumab with radiation therapy in early-stage triple-negative breast cancer
Time restricted eating modulates gut microbiome and metabolome to improve immunotherapy outcomes in African American (AA) patients with Head and Neck squamous cell cancer (HNSCC)
Novel mechanisms and new pharmacological targets within the Brain-Gut Microbiome-Immune axis with the long-term goal of improving treatment strategies for MetS.
R-HTN-associated gut dysbiosis alters gut-brain axis and antihypertensive drugs’ efficacy
Flavonoids and Microbiome Interactions via Triple Recycling and their Roles in Food-borne Carcinogen-induced Colorectal Cancer